Contents

Current Pharmaceutical Biotechnology, Volume 9 - Number 1

Editorial [Hot Topic:Metalloproteinases Revisited (Guest Editor: Marcia L. Moss)]

, 9(1): 1

Marcia L. Moss


DOI: 10.2174/138920108783497640




ADAM10 as a Target for Anti-Cancer Therapy

, 9(1): 2 - 8

Marcia L. Moss, Alexander Stoeck, Wenbo Yan and Peter J. Dempsey


DOI: 10.2174/138920108783497613




Mechanism and Inhibition of LpxC: An Essential Zinc-Dependent Deacetylase of Bacterial Lipid A Synthesis

, 9(1): 9 - 15

Pei Zhou and Adam W. Barb


DOI: 10.2174/138920108783497668




Will the Real Aggrecanase(s) Step Up: Evaluating the Criteria that Define Aggrecanase Activity in Osteoarthritis

, 9(1): 16 - 23

M. D. Tortorella and A. M. Malfait


DOI: 10.2174/138920108783497622




Discovery and Development of Anthrax Lethal Factor Metalloproteinase Inhibitors

, 9(1): 24 - 33

Benjamin E. Turk


DOI: 10.2174/138920108783497604




Matrix Metalloproteinase-9/Gelatinase B is a Putative Therapeutic Target of Chronic Obstructive Pulmonary Disease and Multiple Sclerosis

, 9(1): 34 - 46

Q.-X. Sang, M. E. Muroski, M. D. Roycik, R. G. Newcomer, P. E. Van den Steen, G. Opdenakker, H. R. Monroe and Z. J. Sahab


DOI: 10.2174/138920108783497631




Joint Diseases and Matrix Metalloproteinases: A Role for MMP-13

, 9(1): 47 - 54

Hironari Takaishi, Tokuhiro Kimura, Seema Dalal, Yasunori Okada and Jeanine D'Armiento


DOI: 10.2174/138920108783497659




Webmaster Contact: info@benthamscience.org
Copyright © 2018 Bentham Science